XSS in Oretnom23 Clinic\'s Patient Management System
CVE-2024-8554
A vulnerability was found in SourceCodester Clinics Patient Management System 2.0 and classified as problematic. This issue affects some unknown processing of the file /users.php. The manipulation of the argument message leads to cross site scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used.
Vulnerability class: XSS (Cross-Site Scripting)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 3.5 (Low). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N.
EPSS exploit prediction
EPSS: 0.005 (39.6th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 40th percentile — 39.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.005 · newest: 0.005 · change: 0.000
Affected products
- Oretnom23 Clinic\'s Patient Management System — versions 2.0
- Sourcecodester Clinics Patient Management System — versions 2.0
Weakness classification (CWE)
Public proof-of-concept exploits
References
- vuldb.com/ (Permissions Required, technical-description, VDB Entry, Third Party Advisory, vdb-entry)
- vuldb.com/ (signature, Permissions Required, permissions-required, VDB Entry, Third Party Advisory)
- vuldb.com/ (VDB Entry, Third Party Advisory, third-party-advisory)
- github.com/gurudattch/CVEs/blob/main/Sourcecodester-Clinic's-Patient-Management… (Exploit, Third Party Advisory, exploit)
- www.sourcecodester.com/ (Product, product)
Frequently asked questions
- What is CVE-2024-8554?
- CVE-2024-8554 is a low-severity vulnerability in Oretnom23 Clinic\'s Patient Management System, classified under Cross-site Scripting. CVSS score: 3.5/10. Published 2024-09-07.
- How severe is CVE-2024-8554?
- Low severity. CVSS v3 base score is 3.5 out of 10.
- Is CVE-2024-8554 known to be exploited?
- 2 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.